yingweiwo

GPR

GPR

GPR related products

Structure Cat No. Product Name CAS No. Product Description
AF64394 V6494 AF64394 1637300-25-4 AF64394 is an inverse agonist of GPR3 with pIC50 of 7.3.
APD 668 V3354 APD 668 832714-46-2 APD668 (also known as JNJ-28630368) is a novel and potent agonist of the pancreatic and GI-expressed orphan G-protein coupled receptor GPR119, with EC50 of 2.7 nM and 33 nM for hGPR119 and ratGPR119 respectively.
APD597 (JNJ38431055) V2826 APD597 (JNJ38431055) 897732-93-3 APD597 (formerly known as JNJ-38431055) is a novel potent and selective GPR119 agonist/modulator, which has the potential for the treatment of type 2 diabetes.
AR 231453 V29481 AR 231453 733750-99-7 AR231453 (AR-231453) is a potent, selective and orally bioavailable GPR119 agonist used as an antidiabetic agent.
CID-16020046 V5220 CID-16020046 834903-43-4 CID-16020046 (CI-16020046) is a novel, potent and selective GPR55 (LPI receptor) antagonist / inverse agonist which can block GPR55-mediated endothelial wound healing and reverse LPI-inhibited platelet aggregation.
DC260126 V30807 DC260126 346692-04-4 DC260126 is a potent GPR40 (FFAR1) antagonist.
DJ-V159 V3999 DJ-V159 2253744-53-3 DJ-V-159 is a novel and potent agonist for G protein-coupled receptor family C group 6 member A(GPRC6A) with the potential for treating type 2 diabetes mellitus (T2D).
FTBMT V21384 FTBMT 1358575-02-6 FTBMT is a novel, potent, selective and orally bioavailable GPR52 agonist with antipsychotic and procognitive properties.
GTPL5846 V21931 GTPL5846 83797-69-7 6-OAU (GTPL5846) is a GPR84 (G protein-coupled receptor 84) agonist with EC50 of 105 nM.
JMS-17-2 V22911 JMS-17-2 1380392-05-1 JMS-17-2 is a novel, potent and selective antagonist of CX3CR1 with anticancer activity.
JNJ 63533054 V4029 JNJ 63533054 1802326-66-4 JNJ-63533054, a glycine benzamide analog, is a potent, selective and brain penetrant agonist of hGPR139 (human G-protein-coupled receptors) with an EC50 of 16 nM.
LP-471756 V24432 LP-471756 413605-11-5 LP-471756 is a potent GPR139 antagonist (inhibitor) with IC50 of 640 nM.
MBX-2982 (SAR260093) V25100 MBX-2982 (SAR260093) 1037792-44-1 MBX-2982 (SAR-260093) is a novel, potent, selective and orally bioavailable G protein-coupled receptor 119 (GPR119) agonist with the potential for treating type 2 diabetes.
ML 145 V33730 ML 145 1164500-72-4 ML 145 is a selective, competitive human GPR35/CXCR8 antagonist (inhibitor) with IC50/EC50 of 20.1 nM.
ML-184 (CID-2440433) V18310 ML184 (CID2440433) 794572-10-4 ML-184 (CID244033) is a selective GPR55 agonist with EC50 of 250 nM and is more than 100 times more selective for GPR55 than GPR35, CB1 and CB2.
ML-191 V2292 ML-191 931695-79-3 ML-191 is an antagonist of GPR55.
ML-193 V25659 ML-193 713121-80-3 ML-193 (ML193; CID-1261822; CID1261822) is a novel and potent GPR55 (G protein-coupled receptor 55) antagonist with IC50 of 221 nM.
ML401 V24805 ML401 1597489-14-9 ML401 is a potent chemical probe that selectively antagonizes EBI2 (known also as GPR183) with IC50 of 1.03 nM.
NE 52-QQ57 V32986 NE 52-QQ57 1401728-56-0 NE 52-QQ57 is a selective, orally bioactive GPR4 antagonist (inhibitor) with IC50 of 70 nM.
NIBR-189 V26464 NIBR-189 1599432-08-2 NIBR189 is an antagonist of EBI2 (Epstein-Barr virus-induced gene 2).
Contact Us